Sustained neurobehavioral effects of exposure to SSRI antidepressants during development: molecular to clinical evidence - Wikidata - awgldk - TriplyDB

Sustained neurobehavioral effects of exposure to SSRI antidepressants during development: molecular to clinical evidence

Sustained neurobehavioral effects of exposure to SSRI antidepressants during development: molecular to clinical evidence

http://www.wikidata.org/entity/Q37658594

about

Addiction-related gene regulation: risks of exposure to cognitive enhancers vs. other psychostimulants Optimizing the treatment of mood disorders in the perinatal period Perinatal vs genetic programming of serotonin states associated with anxiety.Olanzapine treatment of adolescent rats causes enduring specific memory impairments and alters cortical development and function.Antidepressant medication during pregnancy and epigenetic changes in umbilical cord blood: a systematic review Serotonin receptor expression in human prefrontal cortex: balancing excitation and inhibition across postnatal development Antidepressants may mitigate the effects of prenatal maternal anxiety on infant auditory sensory gating.Prenatal Cocaine Disrupts Serotonin Signaling-Dependent Behaviors: Implications for Sex Differences, Early Stress and Prenatal SSRI Exposure Dopamine and serotonin signaling during two sensitive developmental periods differentially impact adult aggressive and affective behaviors in mice.Sleep disturbance as detected by actigraphy in pre-pubertal juvenile monkeys receiving therapeutic doses of fluoxetine Early-life serotonin dysregulation affects the migration and positioning of cortical interneuron subtypes.NEUROBIOLOGICAL PREDICTORS OF RESPONSE TO DORSOLATERAL PREFRONTAL CORTEX REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION IN DEPRESSION: A SYSTEMATIC REVIEW.Returning to tricyclic antidepressants for depression during childbearing: clinical and dosing challenges.Fluoxetine during development reverses the effects of prenatal stress on depressive-like behavior and hippocampal neurogenesis in adolescence Fetal, maternal, and placental sources of serotonin and new implications for developmental programming of the brain Neonatal pharmacology: rational therapeutics for the most vulnerable Postnatal day 2 to 11 constitutes a 5-HT-sensitive period impacting adult mPFC function.New insights into perinatal depression: pathogenesis and treatment during pregnancy and postpartum.Psychoactive pharmaceuticals induce fish gene expression profiles associated with human idiopathic autism Developmental exposure to fluoxetine modulates the serotonin system in hypothalamus.Pharmacokinetics of fluoxetine in pregnant baboons (Papio spp.).Early-life exposure to the SSRI paroxetine exacerbates depression-like behavior in anxiety/depression-prone rats.A transient placental source of serotonin for the fetal forebrain Serotonin-1A autoreceptors are necessary and sufficient for the normal formation of circuits underlying innate anxiety Olanzapine antipsychotic treatment of adolescent rats causes long term changes in glutamate and GABA levels in the nucleus accumbens.Ontogeny and regulation of the serotonin transporter: providing insights into human disorders.The serotonergic anatomy of the developing human medulla oblongata: implications for pediatric disorders of homeostasis Maternal depression and anxiety are associated with altered gene expression in the human placenta without modification by antidepressant use: implications for fetal programming Placental source for 5-HT that tunes fetal brain development.The effects of depression and use of antidepressive medicines during pregnancy on the methylation status of the IGF2 imprinted control regions in the offspring.Perinatal citalopram exposure selectively increases locus ceruleus circuit function in male rats.Neonatal SSRI Exposure Programs a Hypermetabolic State in Adult Mice.The SSRI citalopram affects fetal thalamic axon responsiveness to netrin-1 in vitro independently of SERT antagonism.Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants in Pregnancy and Congenital Anomalies: Analysis of Linked Databases in Wales, Norway and Funen, Denmark.Prenatal exposure to antidepressants and depressed maternal mood alter trajectory of infant speech perception.Disruption of 5-HT1A function in adolescence but not early adulthood leads to sustained increases of anxiety Rethinking 5-HT1A receptors: emerging modes of inhibitory feedback of relevance to emotion-related behavior The Roles of Maternal Depression, Serotonin Reuptake Inhibitor Treatment, and Concomitant Benzodiazepine Use on Infant Neurobehavioral Functioning Over the First Postnatal Month.Placental serotonin: implications for the developmental effects of SSRIs and maternal depression Fluoxetine impairs GABAergic signaling in hippocampal slices from neonatal rats.

P2860

Q22251215-FAA731A2-89F1-447C-9509-7906294A3566 Q26798225-46B334E2-EEA5-4E35-86F8-250E42B69517 Q27311047-C79A67F8-4C7B-4282-BB9B-907A564747B3 Q27313333-B1192C29-7335-42E6-B898-367BC5674795 Q28075452-E3B5AC05-28FC-43A1-A720-0305BBFE1FC9 Q28741999-1674CAC5-75C0-4BE6-B0A6-653340558DCC Q30453943-E6A066EC-C639-45D0-A7A4-0584005CC1A9 Q30469931-EE82370E-4837-4076-A1B9-CAF4EA9E0A71 Q30619328-59A3149E-D968-46D7-BE27-95B0ABB6D496 Q30762930-B336F734-9268-4FF8-85A3-B8DAB9827C82 Q30823860-427D8866-2F08-498E-96ED-5B779FC25F1D Q30994290-E22FCCCA-58D0-4B6A-A41B-CDF465654FCD Q33976001-717D5773-C4CD-4C18-8AF1-58189A6B836F Q34017808-6EED0B84-85ED-4243-9D2E-B2AA4399E9A7 Q34029017-6F802104-E8FA-44EE-8140-AB7217693E30 Q34088196-6695C713-6DF8-4266-9474-4B9E322A058E Q34162744-A951C429-7811-4CDE-A4FE-3AE7E3E1B6BD Q34177689-E46BC01F-CE06-445C-94F9-F192A5ED8FBB Q34305076-1FAAD3B2-002C-4BF8-ADF8-A8CD5A10C45A Q34576006-96FE0135-5D2E-4E0B-A92C-13A7001F7CFE Q34620074-AE9D8B32-C0E9-4C67-A9EE-6F5ABBC932FE Q34714284-0DD1231F-263A-48B6-8B5B-75A9DE1F75B4 Q34881930-D0748118-742C-4606-9226-E74787C0BE06 Q35008700-A3536340-A291-4F98-8F34-C3C835FC5CB7 Q35021488-E298C005-7919-4A9D-8528-172F41E2548E Q35090255-247AC119-85E0-4FAF-A1F1-AF91AC73FDD4 Q35098779-AC752CE2-AB1F-454A-B143-077ED39B51B3 Q35161157-FC362496-9A32-4CAA-A393-892FEB137832 Q35614116-AB385ECA-34A6-49F4-BFC2-6D0553BAD7FC Q35670663-217318F4-B853-4CFD-8638-B7823FDC373C Q35853507-FC6017AF-5903-4F86-9159-4C222BC09045 Q35909234-7B2B6162-234E-4494-9620-C30A47EDF26F Q36035922-AE65B20A-D9B7-4C98-88A2-3E35EAA14E36 Q36209588-2342F2AC-1740-4605-8786-663F34ACD1A9 Q36336176-B70E434F-16C1-41B6-A95B-7E831D1CF3AA Q36345622-27B3DB8D-FF75-43E2-840F-0DBB8ED91140 Q36540897-724CFF6A-F820-4D90-A4B5-382CD220DF8A Q36547279-6ACC89AE-A58A-4B80-9684-815C1F872C16 Q36785491-E164C533-8B0D-4158-8463-A1F7C3B40334 Q36806023-EC81028D-DB64-45E8-967F-F93F512A3284

P2860

Sustained neurobehavioral effects of exposure to SSRI antidepressants during development: molecular to clinical evidence

http://www.wikidata.org/entity/Q37658594

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Sustained neurobehavioral effe ...... molecular to clinical evidence

@en

Sustained neurobehavioral effe ...... olecular to clinical evidence.

@nl

type

label

Sustained neurobehavioral effe ...... molecular to clinical evidence

@en

Sustained neurobehavioral effe ...... olecular to clinical evidence.

@nl

prefLabel

Sustained neurobehavioral effe ...... molecular to clinical evidence

@en

Sustained neurobehavioral effe ...... olecular to clinical evidence.

@nl

P1433

Q37658594-5137FE99-4DB3-4CBB-AC49-D748E0667A12

P1476

Q37658594-CDE4F4A4-9C51-4CCC-B060-96E913CC14A6

P2093

Q37658594-4D328E2A-2F2D-4244-923D-CEB557B1D929

Q37658594-52AB1C03-6DC6-4268-8656-98D616388945

Q37658594-7745DF94-8B52-4B30-AED1-E445E42F6255

P2860

Q37658594-1B8A2129-2C49-43E5-B7C0-B54DD32575AF

Q37658594-29334B56-3703-4C94-837A-664CBAE3FEC5

Q37658594-309EE58D-591C-464D-A9A2-275E8F2C80EE

Q37658594-3E08E72D-1FB1-4843-B427-7EB7B2858BDF

Q37658594-49BF0D2D-F563-420F-A294-91A7697EA889

Q37658594-541D10A3-B774-4162-8706-F39FF32050A3

Q37658594-5B0A031C-F6FE-4CB3-ACD1-3C3F47A0F0EA

Q37658594-5D530C04-F5E8-4C3B-9475-111A352DD421

Q37658594-5E6A862B-C0FB-428D-A823-388785EBE636

Q37658594-64F0A0FF-D40A-4C1B-A6BC-668F682B910E

P304

Q37658594-CA34A6DD-381E-4FC3-9B14-FA1072C03B72

P31

Q37658594-012BE232-2868-4BB9-9A3D-218FF454BAF7

P356

Q37658594-6E16C596-8BA0-48C1-B687-AB5B0529F04E

P407

Q37658594-C61A93EA-EF37-45F6-991E-5F6892EBE367

P433

Q37658594-F9E6D3BC-59C2-43FA-97D3-CD052C8AD263

P478

Q37658594-E7F589AD-8D66-4D0A-846B-17527DB20D4C

P577

Q37658594-500377F1-0275-4F36-99A5-D6E661F67B78

P5875

Q37658594-9661A4C5-CE70-4FD2-B84E-7777E6C21067

P698

Q37658594-63B3E622-3F2A-4FCD-81AD-41267353F2EE

P932

Q37658594-708A029C-2F08-41E2-BC5E-7F461424303B

P356

P1433

Clinical Pharmacology & Therapeutics

P1476

Sustained neurobehavioral effe ...... molecular to clinical evidence

@en

P2093

J A Gingrich

http://www.w3.org/2001/XMLSchema#string

M S Ansorge

http://www.w3.org/2001/XMLSchema#string

T F Oberlander

http://www.w3.org/2001/XMLSchema#string

P2860

Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry

Neurodevelopment of children exposed in utero to antidepressant drugs

Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data.

Lasting syndrome of depression produced by reduction in serotonin uptake during postnatal development: evidence from sleep, stress, and behavior.

A new animal model of endogenous depression: a summary of present findings.

Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations.

Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice.

Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications.

Inhibition of serotonin but not norepinephrine transport during development produces delayed, persistent perturbations of emotional behaviors in mice.

Effect of exposure to selective serotonin reuptake inhibitors in utero on fetal growth: potential role for the IGF-I and HPA axes.

P304

672-677

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/CLPT.2009.201

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

86

http://www.w3.org/2001/XMLSchema#string

P577

2009-11-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38067900

http://www.w3.org/2001/XMLSchema#string

P698

19890255

http://www.w3.org/2001/XMLSchema#string

P932

3963518

http://www.w3.org/2001/XMLSchema#string